Details for New Drug Application (NDA): 018485
✉ Email this page to a colleague
NDA 018485 describes ISOPTIN, which is a drug marketed by Mt Adams and is included in two NDAs. Additional details are available on the ISOPTIN profile page.
The generic ingredient in ISOPTIN is verapamil hydrochloride. There are seventeen drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the verapamil hydrochloride profile page.
The generic ingredient in ISOPTIN is verapamil hydrochloride. There are seventeen drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the verapamil hydrochloride profile page.
Summary for 018485
| Tradename: | ISOPTIN |
| Applicant: | Mt Adams |
| Ingredient: | verapamil hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 018485
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 2.5MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
